406 related articles for article (PubMed ID: 28024639)
1. Soluble telmisartan bearing poly (ethylene glycol) conjugated chitosan nanoparticles augmented drug delivery, cytotoxicity, apoptosis and cellular uptake in human cervical cancer cells.
Sharma A; Jyoti K; Bansal V; Jain UK; Bhushan B; Madan J
Mater Sci Eng C Mater Biol Appl; 2017 Mar; 72():69-76. PubMed ID: 28024639
[TBL] [Abstract][Full Text] [Related]
2. Chitosan grafted-poly(ethylene glycol) methacrylate nanoparticles as carrier for controlled release of bevacizumab.
Savin CL; Popa M; Delaite C; Costuleanu M; Costin D; Peptu CA
Mater Sci Eng C Mater Biol Appl; 2019 May; 98():843-860. PubMed ID: 30813091
[TBL] [Abstract][Full Text] [Related]
3. Dissolution properties and physical characterization of telmisartan-chitosan solid dispersions prepared by mechanochemical activation.
Zhong L; Zhu X; Luo X; Su W
AAPS PharmSciTech; 2013 Jun; 14(2):541-50. PubMed ID: 23430728
[TBL] [Abstract][Full Text] [Related]
4. Design, optimization and in vitro-in vivo evaluation of smart nanocaged carrier delivery of multifunctional PEG-chitosan stabilized silybin nanocrystals.
Liu Y; Wang Y; Zhao J
Int J Biol Macromol; 2019 Mar; 124():667-680. PubMed ID: 30502425
[TBL] [Abstract][Full Text] [Related]
5. Amorphous ternary cyclodextrin nanocomposites of telmisartan for oral drug delivery: improved solubility and reduced pharmacokinetic variability.
Sangwai M; Vavia P
Int J Pharm; 2013 Sep; 453(2):423-32. PubMed ID: 22935741
[TBL] [Abstract][Full Text] [Related]
6. Improved cisplatin delivery in cervical cancer cells by utilizing folate-grafted non-aggregated gelatin nanoparticles.
Dixit N; Vaibhav K; Pandey RS; Jain UK; Katare OP; Katyal A; Madan J
Biomed Pharmacother; 2015 Feb; 69():1-10. PubMed ID: 25661330
[TBL] [Abstract][Full Text] [Related]
7. Glycyrrhetinic acid-modified chitosan/poly(ethylene glycol) nanoparticles for liver-targeted delivery.
Tian Q; Zhang CN; Wang XH; Wang W; Huang W; Cha RT; Wang CH; Yuan Z; Liu M; Wan HY; Tang H
Biomaterials; 2010 Jun; 31(17):4748-56. PubMed ID: 20303163
[TBL] [Abstract][Full Text] [Related]
8. Enhanced drug-loading and therapeutic efficacy of hydrotropic oligomer-conjugated glycol chitosan nanoparticles for tumor-targeted paclitaxel delivery.
Koo H; Min KH; Lee SC; Park JH; Park K; Jeong SY; Choi K; Kwon IC; Kim K
J Control Release; 2013 Dec; 172(3):823-31. PubMed ID: 24035978
[TBL] [Abstract][Full Text] [Related]
9. Paclitaxel molecularly imprinted polymer-PEG-folate nanoparticles for targeting anticancer delivery: Characterization and cellular cytotoxicity.
Esfandyari-Manesh M; Darvishi B; Ishkuh FA; Shahmoradi E; Mohammadi A; Javanbakht M; Dinarvand R; Atyabi F
Mater Sci Eng C Mater Biol Appl; 2016 May; 62():626-33. PubMed ID: 26952466
[TBL] [Abstract][Full Text] [Related]
10. Design of fixed dose combination and physicochemical characterization of enteric-coated bilayer tablet with circadian rhythmic variations containing telmisartan and pravastatin sodium.
Luo D; Kim JH; Park C; Oh E; Park JB; Cui JH; Cao QR; Lee BJ
Int J Pharm; 2017 May; 523(1):343-356. PubMed ID: 28330645
[TBL] [Abstract][Full Text] [Related]
11. Sigma-2 receptor ligand anchored telmisartan loaded nanostructured lipid particles augmented drug delivery, cytotoxicity, apoptosis and cellular uptake in prostate cancer cells.
Puri R; Kaur Bhatia R; Shankar Pandey R; Kumar Jain U; Katare OP; Madan J
Drug Dev Ind Pharm; 2016 Dec; 42(12):2020-2030. PubMed ID: 27184705
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and evaluation of PEG-O-chitosan nanoparticles for delivery of poor water soluble drugs: ibuprofen.
Hassani Najafabadi A; Abdouss M; Faghihi S
Mater Sci Eng C Mater Biol Appl; 2014 Aug; 41():91-9. PubMed ID: 24907742
[TBL] [Abstract][Full Text] [Related]
13. Efficient siRNA delivery and tumor accumulation mediated by ionically cross-linked folic acid-poly(ethylene glycol)-chitosan oligosaccharide lactate nanoparticles: for the potential targeted ovarian cancer gene therapy.
Li TS; Yawata T; Honke K
Eur J Pharm Sci; 2014 Feb; 52():48-61. PubMed ID: 24178005
[TBL] [Abstract][Full Text] [Related]
14. Improved pH-dependent drug release and oral exposure of telmisartan, a poorly soluble drug through the formation of drug-aminoclay complex.
Yang L; Shao Y; Han HK
Int J Pharm; 2014 Aug; 471(1-2):258-63. PubMed ID: 24834880
[TBL] [Abstract][Full Text] [Related]
15. Inclusion of telmisartan in mesocellular foam nanoparticles: drug loading and release property.
Zhang Y; Jiang T; Zhang Q; Wang S
Eur J Pharm Biopharm; 2010 Sep; 76(1):17-23. PubMed ID: 20685333
[TBL] [Abstract][Full Text] [Related]
16. Preparation and optimization of PMAA-chitosan-PEG nanoparticles for oral drug delivery.
Pawar H; Douroumis D; Boateng JS
Colloids Surf B Biointerfaces; 2012 Feb; 90():102-8. PubMed ID: 22037474
[TBL] [Abstract][Full Text] [Related]
17. Chitosan-based nanoparticles for survivin targeted siRNA delivery in breast tumor therapy and preventing its metastasis.
Sun P; Huang W; Jin M; Wang Q; Fan B; Kang L; Gao Z
Int J Nanomedicine; 2016; 11():4931-4945. PubMed ID: 27729789
[TBL] [Abstract][Full Text] [Related]
18. Use of combined nanocarrier system based on chitosan nanoparticles and phospholipids complex for improved delivery of ferulic acid.
Telange DR; Jain SP; Pethe AM; Kharkar PS; Rarokar NR
Int J Biol Macromol; 2021 Feb; 171():288-307. PubMed ID: 33418046
[TBL] [Abstract][Full Text] [Related]
19. Transferrin functionalized chitosan-PEG nanoparticles for targeted delivery of paclitaxel to cancer cells.
Nag M; Gajbhiye V; Kesharwani P; Jain NK
Colloids Surf B Biointerfaces; 2016 Dec; 148():363-370. PubMed ID: 27632697
[TBL] [Abstract][Full Text] [Related]
20. Modulation of microenvironmental pH and crystallinity of ionizable telmisartan using alkalizers in solid dispersions for controlled release.
Tran PH; Tran HT; Lee BJ
J Control Release; 2008 Jul; 129(1):59-65. PubMed ID: 18501462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
